Lupus Nephritis Clinical Trials in Omaha, Nebraska

3 studies are recruiting for lupus nephritis in Omaha, Nebraska right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

    The primary objective of this trial is to evaluate the efficacy and safety of FT819, comprised of allogeneic T cells that express a CD19-targeted CAR, following bendamustine administration in participants with refractory moderate-to-severe lupus nephritis, as assessed by the proportion of participa…

    Stage
    Phase 2
    Ages
    12 to 70
    Site
    University of Nebraska Medical Center, Omaha, Nebraska
    Locations
    12 in total
    Run by
    Fate Therapeutics

    See if you can join NCT07570862 on ClinicalTrials.gov

  2. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

    The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    University of Nebraska Medical Center, Omaha, Nebraska
    Locations
    103 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT05268289 on ClinicalTrials.gov

  3. A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

    This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants with moderate-to-severe active systemic lupus erythematosus (SLE) with or without nephritis, antine…

    Stage
    Phase 1
    Ages
    12 to 70
    Site
    University of Nebraska Medical Center, Omaha, Nebraska
    Locations
    21 in total
    Run by
    Fate Therapeutics

    See if you can join NCT06308978 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.